BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306
70 results:

  • 1. Comprehending the cuproptosis and cancer-immunity cycle network: delving into the immune landscape and its predictive role in breast cancer immunotherapy responses and clinical endpoints.
    Liu X; Xu F; Zhao K; Liu Y; Ye G; Zhang X; Qu Y
    Front Immunol; 2024; 15():1344023. PubMed ID: 38312844
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
    Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
    Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cell-In-Cell Structures in Early breast cancer Are Prognostically Valuable.
    Bauer MF; Hildebrand LS; Rosahl MC; Erber R; Schnellhardt S; Büttner-Herold M; Putz F; Ott OJ; Hack CC; Fietkau R; Distel L
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611874
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Patterns of metastases progression- The linear parallel ratio.
    Gofrit ON; Gofrit B; Roditi Y; Popovtzer A; Frank S; Sosna J; Goldberg SN
    PLoS One; 2022; 17(9):e0274942. PubMed ID: 36129954
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Distinct genetic landscape and a low response to doxorubicin in a luminal-A breast cancer cell line of Pakistani origin.
    Shakeel M; Khan SA; Mughal AJ; Irfan M; Hoessli DC; Choudhary MI; Aurongzeb M; Khan IA
    Mol Biol Rep; 2021 Oct; 48(10):6821-6829. PubMed ID: 34495459
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L.
    Wong D; Sogerer L; Lee SS; Wong V; Lum A; Levine AB; Marra MA; Yip S
    BMC Biol; 2020 Oct; 18(1):154. PubMed ID: 33115448
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Heart-breast cancer-on-a-Chip Platform for Disease Modeling and Monitoring of Cardiotoxicity Induced by cancer Chemotherapy.
    Lee J; Mehrotra S; Zare-Eelanjegh E; Rodrigues RO; Akbarinejad A; Ge D; Amato L; Kiaee K; Fang Y; Rosenkranz A; Keung W; Mandal BB; Li RA; Zhang T; Lee H; Dokmeci MR; Zhang YS; Khademhosseini A; Shin SR
    Small; 2021 Apr; 17(15):e2004258. PubMed ID: 33094918
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Capicua restricts cancer stem cell-like properties in breast cancer cells.
    Yoe J; Kim D; Kim S; Lee Y
    Oncogene; 2020 Apr; 39(17):3489-3506. PubMed ID: 32108163
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression profiling identified IL-8 as a regulator of homotypic cell-in-cell formation.
    Ruan B; Wang C; Chen A; Liang J; Niu Z; Zheng Y; Fan J; Gao L; Huang H; Wang X; Sun Q
    BMB Rep; 2018 Aug; 51(8):412-417. PubMed ID: 30021676
    [TBL] [Abstract] [Full Text] [Related]  

  • 10.
    Kasten BB; Oliver PG; Kim H; Fan J; Ferrone S; Zinn KR; Buchsbaum DJ
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561763
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. BCL-X
    Carné Trécesson S; Souazé F; Basseville A; Bernard AC; Pécot J; Lopez J; Bessou M; Sarosiek KA; Letai A; Barillé-Nion S; Valo I; Coqueret O; Guette C; Campone M; Gautier F; Juin PP
    Nat Commun; 2017 Oct; 8(1):1123. PubMed ID: 29066722
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.
    Zhao XL; Lin Y; Jiang J; Tang Z; Yang S; Lu L; Liang Y; Liu X; Tan J; Hu XG; Niu Q; Fu WJ; Yan ZX; Guo DY; Ping YF; Wang JM; Zhang X; Kung HF; Bian XW; Yao XH
    J Pathol; 2017 Nov; 243(3):376-389. PubMed ID: 28802057
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Global and regional patterns of longitudinal strain in screening for chemotherapy-induced cardiotoxicity.
    Portugal G; Moura Branco L; Galrinho A; Mota Carmo M; Timóteo AT; Feliciano J; Abreu J; Duarte Oliveira S; Batarda L; Cruz Ferreira R
    Rev Port Cardiol; 2017 Jan; 36(1):9-15. PubMed ID: 27955938
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Recurrent cic Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
    Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A novel role for an RCAN3-derived peptide as a tumor suppressor in breast cancer.
    Martínez-Høyer S; Solé-Sánchez S; Aguado F; Martínez-Martínez S; Serrano-Candelas E; Hernández JL; Iglesias M; Redondo JM; Casanovas O; Messeguer R; Pérez-Riba M
    Carcinogenesis; 2015 Jul; 36(7):792-9. PubMed ID: 25916653
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Differential remodeling of extracellular matrices by breast cancer initiating cells.
    Raja AM; Xu S; Zhuo S; Tai DC; Sun W; So PT; Welsch RE; Chen CS; Yu H
    J Biophotonics; 2015 Oct; 8(10):804-15. PubMed ID: 25597396
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SLC25A1, or cic, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.
    Kolukula VK; Sahu G; Wellstein A; Rodriguez OC; Preet A; Iacobazzi V; D'Orazi G; Albanese C; Palmieri F; Avantaggiati ML
    Oncotarget; 2014 Mar; 5(5):1212-25. PubMed ID: 24681808
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling.
    Garulli C; Kalogris C; Pietrella L; Bartolacci C; Andreani C; Falconi M; Marchini C; Amici A
    Cell Signal; 2014 Feb; 26(2):352-62. PubMed ID: 24280125
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Ectopically expressed variant form of sperm mitochondria-associated cysteine-rich protein augments tumorigenicity of the stem cell population of lung adenocarcinoma cells.
    Takahashi A; Hirohashi Y; Torigoe T; Tamura Y; Tsukahara T; Kanaseki T; Kochin V; Saijo H; Kubo T; Nakatsugawa M; Asanuma H; Hasegawa T; Kondo T; Sato N
    PLoS One; 2013; 8(11):e69095. PubMed ID: 24244262
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. GRP78 mediates radiation resistance of a stem cell-like subpopulation within the MCF-7 breast cancer cell line.
    Li B; Cheng XL; Yang YP; Li ZQ
    Oncol Rep; 2013 Nov; 30(5):2119-26. PubMed ID: 24002052
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.